[{"address1": "7750 El Camino Real", "address2": "Suite 2A", "city": "Carlsbad", "state": "CA", "zip": "92009", "country": "United States", "phone": "858 704 4900", "website": "https://www.palisadebio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Palisade Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases. The company's lead therapeutic candidate is PALI-2108, a prodrug PDE4 inhibitor that is in phase 1a/b clinical trial for the treatment of ulcerative colitis, as well as under phase 1a clinical trial for the treatment of fibrostenotic crohn's disease. It has a research collaboration and license agreement with Giiant Pharma, Inc. for the development, manufacture, and commercialization of its compounds; a license agreement with the Regents of the University of California for sole purpose of maintaining the Newsoara Co-Development; and a co-development and distribution agreement with Newsoara Biopharma Co., Ltd. The company is headquartered in Carlsbad, California.", "fullTimeEmployees": 8, "companyOfficers": [{"maxAge": 1, "name": "Mr. J. D. Finley", "age": 67, "title": "CEO, CFO & Director", "yearBorn": 1957, "fiscalYear": 2024, "totalPay": 813000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Mitchell Lawrence Jones M.D., Ph.D.", "age": 47, "title": "COO & Chief Medical Officer", "yearBorn": 1977, "fiscalYear": 2024, "totalPay": 581000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Joerg  Heyer Ph.D.", "title": "Head of Translational Science & Medicine", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Sharon  Skare Ph.D.", "title": "Vice President & Global Head of Clinical Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. James  Izanec M.D.", "title": "VP & Head of Clinical Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ryker  Willie", "title": "Senior VP of Finance & Corporate Controller", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 2.2, "open": 2.18, "dayLow": 2.1021, "dayHigh": 2.18, "regularMarketPreviousClose": 2.2, "regularMarketOpen": 2.18, "regularMarketDayLow": 2.1021, "regularMarketDayHigh": 2.18, "payoutRatio": 0.0, "beta": 1.636, "forwardPE": -11.120882, "volume": 1310136, "regularMarketVolume": 1310136, "averageVolume": 9172495, "averageVolume10days": 4651550, "averageDailyVolume10Day": 4651550, "bid": 1.26, "ask": 2.18, "bidSize": 2, "askSize": 2, "marketCap": 320786944, "fiftyTwoWeekLow": 0.53, "fiftyTwoWeekHigh": 2.59, "allTimeHigh": 5627700.0, "allTimeLow": 0.53, "fiftyDayAverage": 1.922, "twoHundredDayAverage": 1.10135, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 315342912, "profitMargins": 0.0, "floatShares": 102195342, "sharesOutstanding": 149003210, "sharesShort": 12819308, "sharesShortPriorMonth": 7946168, "sharesShortPreviousMonthDate": 1763078400, "dateShortInterest": 1765756800, "sharesPercentSharesOut": 0.0859, "heldPercentInsiders": 0.00014999999, "heldPercentInstitutions": 0.40938, "shortRatio": 2.62, "shortPercentOfFloat": 0.086, "impliedSharesOutstanding": 149203210, "bookValue": 0.352, "priceToBook": 6.107955, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -11226000, "trailingEps": -2.07, "forwardEps": -0.19333, "lastSplitFactor": "1:15", "lastSplitDate": 1712534400, "enterpriseToEbitda": -27.531, "52WeekChange": 0.2647059, "SandP52WeekChange": 0.17318606, "quoteType": "EQUITY", "currentPrice": 2.15, "targetHighPrice": 21.0, "targetLowPrice": 6.0, "targetMeanPrice": 11.66667, "targetMedianPrice": 8.0, "recommendationMean": 1.33333, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 3, "totalCash": 5227000, "totalCashPerShare": 0.035, "ebitda": -11454000, "totalDebt": 211000, "quickRatio": 1.508, "currentRatio": 1.963, "debtToEquity": 6.569, "returnOnAssets": -0.87811995, "returnOnEquity": -2.28635, "freeCashflow": -6624500, "operatingCashflow": -10084000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "PALI", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 9172495, "fiftyTwoWeekLowChange": 1.6200001, "fiftyTwoWeekLowChangePercent": 3.0566041, "fiftyTwoWeekRange": "0.53 - 2.59", "fiftyTwoWeekHighChange": -0.43999982, "fiftyTwoWeekHighChangePercent": -0.1698841, "fiftyTwoWeekChangePercent": 26.470589, "dividendDate": 1563408000, "earningsTimestampStart": 1754942400, "earningsTimestampEnd": 1755288000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -2.07, "epsForward": -0.19333, "epsCurrentYear": -0.64667, "priceEpsCurrentYear": -3.3247254, "fiftyDayAverageChange": 0.22800004, "fiftyDayAverageChangePercent": 0.11862645, "twoHundredDayAverageChange": 1.0486501, "twoHundredDayAverageChangePercent": 0.9521498, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Seneca Biopharma, Inc.", "nameChangeDate": "2025-12-26", "averageAnalystRating": "1.3 - Strong Buy", "regularMarketChangePercent": -2.27273, "regularMarketPrice": 2.15, "corporateActions": [], "postMarketTime": 1766794446, "regularMarketTime": 1766782800, "exchange": "NCM", "messageBoardId": "finmb_244367385", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "shortName": "Palisade Bio, Inc.", "longName": "Palisade Bio, Inc.", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1175261400000, "postMarketChangePercent": -0.46511582, "postMarketPrice": 2.14, "postMarketChange": -0.00999999, "regularMarketChange": -0.05, "regularMarketDayRange": "2.1021 - 2.18", "displayName": "Palisade Bio", "trailingPegRatio": null, "__fetch_time": "2025-12-27"}]